Your browser doesn't support javascript.
loading
The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06.
O'Reilly, Daria J; Goeree, Ron A; Tarride, Jean-Eric; James, Collen; Parfrey, Patrick S.
Affiliation
  • O'Reilly DJ; Program for Assessment of Technology in Health (PATH) Research Institute, St. Joseph's Healthcare Hamilton, McMaster University, Hamilton, ON, Canada. oreilld@mcmaster.ca
Can J Clin Pharmacol ; 16(2): e346-59, 2009.
Article in En | MEDLINE | ID: mdl-19531813
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Reimbursement Mechanisms / Antipsychotic Agents / Insurance, Pharmaceutical Services Type of study: Health_economic_evaluation / Observational_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Can J Clin Pharmacol Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2009 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Reimbursement Mechanisms / Antipsychotic Agents / Insurance, Pharmaceutical Services Type of study: Health_economic_evaluation / Observational_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Can J Clin Pharmacol Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2009 Document type: Article Affiliation country: Country of publication: